CVS monthly performance report
Explore CVS's monthly returns, drawdown, and seasonality trends — updated every month.
CVS monthly report
—
Key takeaways
- CVS Health (CVS) closed November 2026 at $89.35, down 1.00% for the month and +12.76% over the trailing 12 months.
- Year-to-date, CVS is +12.59%, outperforming the S&P 500 which has returned +10.62% YTD.
- The stock is trading +0.43% versus its 200-day moving average ($88.97), a bullish technical signal.
- Over the past three years, CVS has underperformed the S&P 500 by −39.59%, with a relative strength index reading of 76.9.
- Win rate over the trailing 39 months stands at 51.3% — 20 positive months versus 18 negative months.
CVS Health ended November 2026 at $89.35, posting a monthly return of −1.00%. The S&P 500 returned −0.18% over the same window, leaving relative performance at −0.82%.
The current quarter stands at +4.27% (Q4 2026 (QTD)), while medium-term trend remains constructive: price is +0.43% versus the 200-day moving average ($88.97).
Year-to-date, CVS is +12.59% against SPY +10.62%, a gap of +1.96%. The stock is currently −19.27% below its 52-week high, with maximum 3-year drawdown at −46.23%.
| Period | CVS | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | −0.49% | −0.36% | −0.13% |
| 1 Week | +6.56% | +2.59% | +3.96% |
| 1 Month | −1.00% | −0.18% | −0.82% |
| 3 Months | −8.04% | −2.37% | −5.67% |
| 6 Months | −8.93% | +0.83% | −9.76% |
| YTD | +12.59% | +10.62% | +1.96% |
| 12 Months | +12.76% | +12.25% | +0.51% |
| 3 Years | +31.78% | +71.37% | −39.59% |
| Rank | Month | Return |
|---|---|---|
| #1 | Jan 2025 | +25.82% |
| #2 | Aug 2025 | +17.79% |
| #3 | Feb 2025 | +16.36% |
| #4 | Dec 2023 | +16.20% |
| #5 | Apr 2026 | +15.97% |
| Rank | Month | Return |
|---|---|---|
| #1 | Dec 2024 | −25.00% |
| #2 | Apr 2024 | −15.11% |
| #3 | May 2024 | −11.98% |
| #4 | Oct 2024 | −10.21% |
| #5 | Mar 2026 | −10.11% |
| Quarter | Return |
|---|---|
| Q3 2025 | +9.29% |
| Q4 2025 | +5.27% |
| Q1 2026 | −9.50% |
| Q2 2026 | +44.04% |
| Q3 2026 | −17.17% |
| Q4 2026 (QTD) | +4.27% |
| Year | Return |
|---|---|
| 2023 | −15.27% |
| 2024 | −43.15% |
| 2025 | +76.79% |
| 2026 | +12.59% |
| Metric | Value |
|---|---|
| 52-Week High | $110.68 (2026-07-22) |
| 52-Week Low | $69.51 (2026-03-30) |
| Current Price | $89.35 |
| 200-Day Moving Average | $88.97 |
| Price vs 200DMA | +0.43% |
| 3-Year Maximum Drawdown | −46.23% (2024-12-19) |
| Current Drawdown from 52W High | −19.27% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 76.9 |
| 3-Year Excess Return vs S&P 500 | −39.59% |
| RS Peak | 113 (Jan 2024) |
| RS Trough | 47.3 (Dec 2024) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was CVS's return for this report period?
CVS returned −1.00% in the latest monthly window ending 2026-11-13.
Has CVS outperformed SPY year to date?
YTD CVS: +12.59% vs SPY: +10.62%.
What is CVS's 12-month return?
+12.76% over the trailing 12 months.
Is CVS above or below its 200-day moving average?
Price is +0.43% versus 200DMA ($88.97).
What is the maximum drawdown in the 3-year window?
−46.23% on 2024-12-19.